| A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms (NCT05444530) | Janssen Research & Development, LLC | 2022-07-21 |
| Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF. (NCT04866056) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2021-09-30 |
| Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders (NCT04761770) | Memorial Sloan Kettering Cancer Center | 2021-02-15 |
| A Study of TQ05105 Tablets in Subjects With Myeloproliferative Neoplasms (NCT04339400) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2018-11-20 |
| Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders (NCT03314974) | Masonic Cancer Center, University of Minnesota | 2018-03-30 |
| Registry of Patients With MPNs in Taiwan (NCT03618485) | Chang Gung Memorial Hospital | 2017-04-01 |
| Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative Disorders (NCT02823210) | Assistance Publique - Hôpitaux de Paris | 2016-06-01 |
| A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms (NCT03075826) | Weill Medical College of Cornell University | 2016-03-15 |
| Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) (NCT02393248) | Incyte Corporation | 2015-02-27 |
| A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders (NCT02125318) | Galena Biopharma, Inc. | 2014-05-01 |
| Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML (NCT02076191) | John Mascarenhas | 2014-02-01 |
| Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms (NCT02084563) | Hospital Israelita Albert Einstein | 2012-10-01 |
| HSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), and Refractory PV/ET (NCT01668173) | Memorial Sloan Kettering Cancer Center | 2012-08-01 |
| Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage (NCT00949364) | University of Ulm | 2009-12-01 |
| Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer (NCT00053196) | Alliance for Clinical Trials in Oncology | 2002-12-01 |